Anti-GLO1 antibody [EPR8878]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Recombinant Monoclonal GLO1 antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Human, Mouse samples. Cited in 8 publications.
View Alternative Names
Lactoylglutathione lyase, Aldoketomutase, Glyoxalase I, Ketone-aldehyde mutase, Methylglyoxalase, S-D-lactoylglutathione methylglyoxal lyase, Glx I, GLO1
- WB
Unknown
Western blot - Anti-GLO1 antibody [EPR8878] (AB137098)
All lanes:
Western blot - Anti-GLO1 antibody [EPR8878] (ab137098) at 1/1000 dilution
Lane 1:
Molt-4 cell lysate at 10 µg
Lane 2:
Raji cell lysate at 10 µg
Lane 3:
TF-1 cell lysate at 10 µg
Lane 4:
HeLa cell lysate at 10 µg
Lane 5:
Red blood cell lysate at 10 µg
Secondary
All lanes:
HRP-labelled Goat anti-Rabbit at 1/2000 dilution
Predicted band size: 21 kDa
false
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-GLO1 antibody [EPR8878] (AB137098)
Intracellular flow cytometric analysis of permeabilized Molt-4 cells labelling GLO1 with ab137098 at 1/10 dilution (red). Negative Rabbit IgG shown in green.
- WB
Lab
Western blot - Anti-GLO1 antibody [EPR8878] (AB137098)
Lanes 1 - 4 : Merged signal (red and green). Green - ab137098 observed at 21 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab137098 was shown to specifically react with in wild-type HAP1 cells as signal was lost in GLO1 knockout cells. Wild-type and GLO1 knockout samples were subjected to SDS-PAGE. The membrane was blocked with 3% Milk. ab137098 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-GLO1 antibody [EPR8878] (ab137098) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
GLO1 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa whole cell lysate at 20 µg
Lane 4:
HepG2 whole cell lysate at 20 µg
Predicted band size: 21 kDa
false
Related conjugates and formulations (1)
-
Anti-GLO1 antibody [EPR8878] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Glyoxalase I is important for maintaining cellular homeostasis by mitigating harmful compounds. It forms part of the glyoxalase system which includes glyoxalase II functioning downstream of GLO1. This system prevents the accumulation of advanced glycation end-products (AGEs) which are implicated in cellular aging and dysfunction. By reducing the levels of methylglyoxal GLO1 supports normal physiological processes and protects cellular integrity.
Pathways
Glyoxalase I is an important component of the glyoxalase pathway. This pathway integrates into the detoxification network working alongside other important enzymes such as superoxide dismutase and catalase. These relationships highlight its function in cellular oxidative stress responses. GLO1's activity impacts pathways related to glycolysis and overall energy metabolism due to its role in reducing metabolic byproducts.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Signal transduction and targeted therapy 10:200 PubMed40571693
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cells 14: PubMed40136646
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 84:2036-2052.e7 PubMed38688279
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 32:108160 PubMed32966793
2020
Applications
Unspecified application
Species
Unspecified reactive species
eLife 9: PubMed32795389
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of leukocyte biology 109:605-619 PubMed32678947
2020
Applications
Unspecified application
Species
Unspecified reactive species
Translational psychiatry 9:260 PubMed31624233
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 40:1182-1192 PubMed31366299
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com